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The longevity-promoting NAD+–dependent class III histone deacety-
lase Sirtuin 1 (SIRT1) is involved in stem cell function by controlling
cell fatedecisionand/orbyregulating thep53-dependentexpression
of NANOG. We show that SIRT1 is down-regulated precisely during
human embryonic stem cell differentiation at both mRNA and pro-
tein levels and that the decrease in Sirt1mRNA is mediated by amo-
lecular pathway that involves the RNA-binding protein HuR and the
arginine methyltransferase coactivator-associated arginine methyl-
transferase 1 (CARM1). SIRT1 down-regulation leads to reactivation
ofkeydevelopmentalgenes suchas theneuroretinalmorphogenesis
effectors DLL4, TBX3, and PAX6, which are epigenetically repressed
by this histone deacetylase in pluripotent human embryonic stem
cells. Our results indicate that SIRT1 is regulated during stem cell
differentiation in the context of a yet-unknown epigenetic pathway
that controls speciﬁc developmental genes in embryonic stem cells.
coactivator-associated arginine methyltransferase 1 | HuR | neural
differentiation | embryonic stem cells
Sirtuin 1 (SIRT1) is an NAD
+-dependent lysine deacetylase in-
volved in multiple cellular events, including chromatin remod-
eling, transcriptional silencing, mitosis, stress responses, DNA
repair, apoptosis, cell cycle, genomic stability, insulin regulation,
and control of lifespan (see ref. 1 for a review). Inmammals, SIRT1
function ismediated by its deacetylating activity not only on histone
tails (mainly K16-H4 and K9-H3 positions; refs. 2–4), but also on
key transcription factors such as p53 (p53), forkhead transcription
factors (FOXO), p300 histone acetyltransferase, the tumor protein
p73 (p73), E2F transcription factor 1 (E2F1), the DNA repair
factorKuantigen, the70-kDasubunit (Ku70), thenuclear factorκ-B
(NF-κB), and the androgen receptor (AR) (see ref. 1 for a review).
Recent studies in mouse models suggest the importance of
Sirt1 in stem cell differentiation. Sirt1 inﬂuences the neural and
glial speciﬁcation of neural precursors (5), regulates differenti-
ation of skeletal myoblast (6), and inhibits spermatogenesis (7).
Independently generated Sirt1-deﬁcient mice are reported to
exhibit severe neural defects, including exencephaly and dis-
turbed neuroretinal morphogenesis (8, 9). In contrast to mice, in
man the role of SIRT1 in human embryonic stem cell (hESC)
differentiation is poorly understood. Here, we report a pathway
that down-regulates SIRT1 during stem cell differentiation. In
addition, we demonstrate that SIRT1 regulates the expression of
speciﬁc developmental genes in pluripotent hESC and, thus, that
its down-regulation is necessary for correct establishment of
speciﬁc differentiation programs during stem cell differentiation.
Results
SIRT1 Is Down-Regulated During hESC Differentiation. To study the
putative role of SIRT1 in hESC differentiation, we ﬁrst mea-
sured SIRT1 mRNA levels during the course of in vitro differ-
entiation of the hESC lines Shef-1 andH-181.Withdrawal of basic
ﬁbroblast growth factor (bFGF) and feeder cells causes sponta-
neous differentiation of both hESC lines into embryonic bodies
(EB) (Fig. 1A) (10). We observed that 15 d after induction of
differentiation, SIRT1 mRNA levels were 60% lower in Shef-1
and 50% lower in H-181 cells (Fig. 1B). Consistent with this obser-
vation, there was a marked reduction in SIRT1 protein levels in 15-
d EB compared with hESC (Fig. 1C), as previously shown in mice
(11). To further characterize SIRT1 down-regulation during hESC
differentiation, we performed immunoﬂuorescence staining of
SIRT1 in hESC and 15-d EB. SIRT1 staining in hESC was mostly
nuclear except during mitosis, when it was diffused in the cytoplasm
(Fig. 1D). In 15-d EB, SIRT1 staining levels were lower and its dis-
tribution was heterogeneous in distinct cell populations (Fig. 1D).
Costaining of disaggregatedEB cells for SIRT1 and for pluripotency/
differentiation markers showed that cells with higher SIRT1 levels
also had higher levels of the marker of pluripotency OCT4 (Fig.
S1A); immunoﬂuorescence analysis corroborated SIRT1 and OCT4
costaining (Fig. S1B). These analyses also showed that MAP2- and
TUBB3-expressing neuroectodermal cells did not express high
SIRT1 levels (Fig. S1 A and B).
To characterize precisely the down-regulation of SIRT1 during
hESCdifferentiation,weassessedRNAandproteins levels ina time-
course experimentduring spontaneousdifferentiationofShef-1 cells
into EB and subsequently into ﬁbroblast-like (F-L) cells. These cells
were obtained by inducing EB attachment, followed by culture in
DMEMwith 15% FBS for an additional 15 d (Fig. 1A) (10). SIRT1
mRNA levels decreased gradually during hESC differentiation,
whereas SIRT1 protein levels dropped markedly only 7 d after in-
duction of differentiation, and remained low throughout the pro-
cess (30 d) (Fig. S1C); this observation suggests that SIRT1 is
regulated during hESC differentiation at more than one level.
SIRT1 mRNA Is Stabilized by Coactivator-Associated Arginine Methyl-
transferase 1 (CARM1)-Dependent Methylated HuR in Pluripotent hESC.
We next studied the molecular mechanisms involved in SIRT1
down-regulation during hESC differentiation. We tested several
possible ways to regulate SIRT1, including SIRT1 promoter epige-
netic status and activity (Fig. S2A andB, respectively), expression of
the SIRT1 regulator miR34a (12) (Fig. S2C), and phosphorylation
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status of SIRT1 (13) (Fig. S2D), but observed no changes that justify
SIRT1 down-regulation during differentiation. It was proposed that,
in cancer cells, SIRT1 RNA stability can be regulated by the RNA-
binding protein HuR (14), which also has a role in cell differentia-
tion (15).
Wehypothesized thatHuR regulates SIRT1RNAstability during
hESC differentiation. To test this possibility, we examined the sta-
bility of SIRT1 RNA by treating cells with actinomycin D to inhibit
de novo transcription. We monitored levels of SIRT1 mRNA and
the housekeeping control GAPDH mRNA by retrotranscription,
followed by quantitative PCR (qPCR) assays, and found that SIRT1
mRNA was notably less stable in differentiating EB than in plurip-
otent hESC (Fig. 2A). GAPDH mRNA, which is not a HuR target
(16), showed no differences between hESC and EB. To determine
whether the decrease in SIRT1 stability was due speciﬁcally toHuR,
we measured the amount of SIRT1 mRNA bound to HuR during
hESC differentiation, using immunoprecipitation (IP) assays and by
monitoring RNA using qPCR. We observed a clear decrease in the
amount of SIRT1 RNA bound to HuR in 15-d EB compared with
hESC (Fig. 2B), which suggests that the decrease in SIRT1 RNA
during hESC differentiation is mediated by the loss of HuR/SIRT1
mRNAbinding. To conﬁrm SIRT1 regulation by HuR, we depleted
HuR in the Shef-1 hESC line with siRNA.HuR silencing resulted in
a marked reduction in SIRT1 (Fig. 2C), further evidence of HuR-
mediated regulation of SIRT1 mRNA stability in hESC.
HuRbinding to β-catenin, another independentHuR target, also
decreased during hESC differentiation (Fig. S2E), which suggests
that global HuR activity is also regulated during hESC differenti-
ation. To test this possibility, we measured HuR mRNA levels in
hESC and 15-d EB, but only found minor differences between the
two cell types (Fig. S2F) and the HuR protein level did not change
during hESCdifferentiation (Fig. 2D andE). BecauseHuR activity
is reported to be regulated by its nucleocytoplasmic shuttling (17,
18), we examined cellular localization of HuR during hESC dif-
ferentiation.Western blot (WB) of nuclear and cytoplasmic extracts
of hESCand15-dEB in theShef-1 andH-181 cell lines showed that,
in both cases, HuR was primarily nuclear and its location did not
change during hESC differentiation. This result implies that
nucleocytoplasmic shuttling ofHuR is not themainmechanism that
regulates HuR activity in hESC. HuR binding to target mRNA is
regulated by Chk2-dependent phosphorylation in cancer cells (14).
To determine whether HuR is regulated by phosphorylation during
stem cell differentiation, we immunoprecipitated total HuR in
Shef-1 cells andEBand analyzed its phosphorylation status by using
an antibody to phosphorylated serine. Phosphorylated HuR levels
did not change notably during hESC differentiation (Fig. S2G),
suggesting that serine phosphorylation is not the primary mecha-
nism of HuR regulation during stem cell differentiation.
HuR is regulated by CARM1-dependent methylation at Arg217
(19). To evaluate whether HuR is regulated by methylation during
hESC differentiation, we measured methyl-HuR levels in hESC and
15-d EB and found a marked reduction in methylated HuR in dif-
ferentiated cells (Fig. 2E). To determine whether this decrease is
speciﬁcallyCARM1-dependent, weused three siRNAtodeplete this
arginine methyltransferase in Shef-1 hESC. CARM1 knockdown
resulted in the loss of methyl-HuR and a marked decrease in SIRT1
(Fig. 2F). Finally, to verify that CARM1-dependent HuR methyla-
tion regulates SIRT1 mRNA stability during hESC differentiation,
we measured CARM1 levels in hESC and EB over time and de-
termined methyl-HuR binding to SIRT1 during hESC differentia-
tion. The decrease in SIRT1 during hESC differentiation was
associated with a decrease in CARM1 (Fig. 2G), and methyl-HuR
binding to SIRT1 was much lower in EB than in hESC (Fig. 2H).
To conﬁrm that HuR methylation inﬂuences HuR binding to
SIRT1 mRNA during hESC differentiation, we compared the
amount of SIRT1 mRNA bound to HuR in Shef-1 cells trans-
fected with two Arg217 HuR mutants (Arg217/Lys, Arg217/Ala)
resistant to CARM1-dependent methylation to Shef-1 cells
transfected with WT HuR. IP assays using an antibody to the V5
epitope tag in our constructs and a control antibody to methyl-
HuR showed that CARM1 methylation-resistant HuR mutants
bound considerably less SIRT1 mRNA than did WT HuR and
methyl-HuR (Fig. 2I). These results suggest that SIRT1 down-
regulation during hESC differentiation is mediated by a CARM1-
dependent decrease in methyl-HuR/SIRT1 mRNA binding.
SIRT1 Epigenetically RegulatesDevelopmental Genes During Pluripotent
hESC Differentiation. SIRT1 was shown to regulate the promoter of
theMashI gene in somatic stem cell neural differentiation in mice
(5). To identify the downstream effects of SIRT1 down-regulation
in hESCdifferentiation, we performed chromatin IP (ChIP) experi-
ments in Shef-1 hESC by using an anti-SIRT1 antibody and by
hybridizing the immunoprecipitated DNA fragments on an Agilent
human promoter ChIP-on-chip microarray containing 474,392
probes, which cover almost all described human promoters and
many known regulatory regions. These experiments showed sig-
niﬁcant binding to 428 probes (0.09% of the total), corresponding
to 353 gene promoters (because some have more than one probe
and some are divergent promoters that regulate two genes), four
intergenic regions, and four microRNA promoters; the exact ge-
nomic location of each SIRT1-positive probe is presented in
Dataset S1. Gene ontology analysis of the SIRT1-bound genes
showed nonrandom distribution, largely with respect to molecular
function (Table 1 and Datasets S2 and S3). SIRT1-bound genes in
hESC are greatly enriched for gene ontology (GO) terms related
to development and differentiation, such as developmental process,
multicellular organismal development, and cell differentiation
(P = 10−10 to 10−4; Table 1). Of the 353 SIRT1-positive genes,
97 are described by the highest-ranking GO term 0032502∼
developmental process (1.76-fold enrichment; P = 3.05 × 10−9;
Table 1). These observations suggest that SIRT1 is involved in the
regulation of speciﬁc developmental genes in hESC.
To validate these data, weperformedChIP experiments in Shef-1
hESC and EB by using antibodies to SIRT1 and to AcK16-H4 and
AcK9-H3, two of its known histone targets (2, 5). The relative
abundance of speciﬁc DNA fragments within the immunoprecipi-
tated chromatin was assessed by quantitative PCR (qChIP). We
randomly selected 10 of the 97 SIRT1-positive genes classiﬁed
within the GO term “developmental process” (DLL4, LHX1,
PAX6, WNT6, BMP1, HES7, TBX3, SERPINE1, HOXA5, TIMP1;
for more information, see SI Materials and Methods). As controls,
we usedGAPDHand rDNA. These experiments showed that all 10
geneswereenriched inSIRT1 inhESC(signiﬁcant inmost cases,P<
0.05; Fig. 3A and Fig. S3A), conﬁrming the consistency of the whole
ChIP-on-chip data. In 15-d EB (which have very low SIRT1 levels
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Fig. 1. Down-regulation of SIRT1 during hESC differentiation. (A) Flowchart
of in vitro hESC differentiation. Representative images of hESC (ES), EB, and
F-L cells were obtained by phase-contrast microscopy. hESC differentiated to
EB after bFGF withdrawal and growth in suspension for 15 d. F-L cells were
obtained by EB attachment on gelatin-coated plates and culture in DMEM +
15% FBS. (B) qPCR analyses of SIRT1mRNA levels in hESC (ES) cells and 15-d EB
(EB15) from Shef-1 and H-181 lines. Results are shown as the amount of SIRT1
mRNA relative to control GAPDH mRNA. (C) WB analysis of the samples in
B using an anti-SIRT1 and anti-α-tubulin (control) antibodies. (D) Confocal
ﬂuorescencemicroscopy assay showing the cell localization of SIRT1 (green) in
Shef-1 undifferentiated hESC and 15-d EB. qPCR values aremean± SDof three
independent experiments.
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relative to hESC), we also observed a marked increase for the best-
known SIRT1 histone targets, AcK16-H4 and AcK9-H3, in most
target genes analyzed (Fig. 3B and Fig. S3B). The GAPDH and
rDNAcontrols showed no SIRT1 enrichment or signiﬁcant changes
inAcK16-H4orAcK9-H3.Toverify direct regulation of these genes
by SIRT1,wedepleted its activity by siRNA inShef-1 cells (Fig. S3C
and D) and used qPCR to measure the mRNA levels of ﬁve target
genes (DLL4, TBX3, SERPINE1, WNT6, PAX6) with GAPDH as
control. SIRT1 knockdown resulted in signiﬁcant up-regulation of
all ﬁve targets (P < 0.05; Fig. 3C), supporting its role in regulating
selected genes in hESC. We also found that mRNA levels of eight
genes were clearly up-regulated in 7- and 14-d EB, which are char-
acterized by low SIRT1 levels (Fig. S3E). These data suggest that
SIRT1 regulation of speciﬁc developmental genes during hESC
differentiation is mediated by epigenetic mechanisms that involve
its histone deacetylase activity.
SIRT1 Is Involved in Lineage Speciﬁcation During hESC Differentiation.
To study the functional role of SIRT1 down-regulation during
hESC differentiation, we used the TaqMan Human Stem Cell
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Fig. 2. CARM1-dependent HuR
stabilizing activity in SIRT1 mRNA.
(A) mRNA stability assay of SIRT1
andGAPDH in Shef-1 hESC (ES) and
3-d EB (EB) after actinomycin D
treatment and collection as indi-
cated. Data are relative to mRNA
levels at t = 0 h for each sample.
(B) RNA IP of HuR in hESC (ES) and
15-d EB (EB15) of Shef-1 and H-181
hESC lines. SIRT1 levels were de-
tectedbyqPCR(relative toGAPDH).
(C)WBofHuR, SIRT1, andα-tubulin
in Shef-1 cells, 3 dafter transfection
with control (SCR) andHuR-speciﬁc
siRNA (iHuR). (D) WB of HuR cyto-
plasmic and nuclear protein frac-
tions from Shef-1 and H-181 hESC
(ES)andEB.Nucleolinandα-tubulin
were used as nuclear and cytoplas-
micmarkers, respectively. (E)Meth-
ylation of HuR analyzed by WB,
using an antibody speciﬁc for HuR
methylated in Arg217 (methyl-
HuR), relative to total HuR during
EB differentiation of Shef-1 and H-
181 hESC lines. (F) WB of CARM1,
methyl-HuR, total HuR, SIRT1, and
α-tubulin in Shef-1 cells at day
3 after transfection with a control
siRNA (SCR) and three speciﬁc
siRNA oligonucleotides for CARM1
(iCARM1, ol1, ol2, ol3). (G) WB of
CARM1 in undifferentiated Shef-1
hESC and EB differentiated for 5,
10, or 15 d (EB5, EB10, and EB15)
and ﬁbroblast-like (F-L) cells. SIRT1
and Oct4 (POU5F1) were also
tested in the same gel. (H) RNA IP assay of methyl-HuR in hESC (ES) and 15-d EB (EB15) of Shef-1 and H-181 hESC. (I) RNA IP assay with anti-V5 antibody in Shef-1 cells
transfected with pCDNA3.3 plasmid expressing WT HuR, R217/K, or R217/A mutant HuR, all with a V5 tag. As control, Shef-1 cells were transfected with an empty
plasmid, immunoprecipitated with anti-methyl-HuR (CTR) antibody and tested in the same conditions. qPCR values are expressed asmean± SD of three independent
experiments.
Table 1. GO terms signiﬁcantly enriched in SIRT1-bound genes
GO term∼biological process No. of genes P value
GO:0032502∼developmental process 97 3.05E-09
GO:0032501∼multicellular organismal process 104 3.01E-08
GO:0007275∼multicellular organismal development 73 1.50E-07
GO:0048856∼anatomical structure development 68 2.75E-07
GO:0048731∼system development 54 1.76E-05
GO:0009653∼anatomical structure morphogenesis 39 3.54E-05
GO:0030154∼cell differentiation 53 1.08E-04
GO:0048869∼cellular developmental process 53 1.08E-04
GO:0035270∼endocrine system development 6 2.45E-04
GO:0003008∼system process 43 4.13E-04
GO:0007154∼cell communication 94 7.75E-04
GO:0048513∼organ development 38 8.78E-04
P < 0.001.
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Pluripotency Array and WB to compare the relative expression of
stemness and differentiation markers during in vitro differentia-
tion of siRNA-mediated SIRT1-depleted Shef-1 cells, mouse
SIRT1 knockout ES cells, andmouse ES cells genetically modiﬁed
to overexpress SIRT1 (20) with their respective wild-type controls.
siRNAdown-regulation of SIRT1 resulted in increased acetylation
of the SIRT1 target p53 (Fig. S3F), consistent with previous reports
(21). Global acetylation of H4K16 remained unchanged (Fig.
S3F), further supporting the idea that SIRT1 histone deacetylase
activity is largely restricted to gene promoters (Fig. 3A andB). This
expression array showed that siRNA-mediated depletion of SIRT1
in hESC altered the expression of only 12% of pluripotency and
9% of differentiation markers (Fig. 4A). Accordingly, protein ex-
pression of pluripotency markers OCT4, NANOG, SOX2, and E-
cadherin was not notably altered (Fig. S3G). The impact of SIRT1
silencing on the expression of pluripotency and differentiation
markers was much greater after induction of differentiation (Fig.
4A); the effect was clearly stronger on expression of developmental
markers (50% in 9-d EB) than on that of pluripotency markers
(31% in 9-d EB) (Fig. 4A).
To study SIRT1 function during ES differentiation in greater
detail, we used several mouse ES cell (mESC) lines: Sirt1 KO, in
which Sirt1 was either inactivated by deletion of exon 4 containing
the catalyticdomain (9), andSuperSirt1, inwhichSirt1was increased
by insertion of an additional copy of the Sirt1 gene (20). Sirt1 ex-
pression was veriﬁed by WB in these mESC lines (Fig. S4A) and
during in vitrodifferentiation (Fig. S4B).As inhumancells, the effect
of Sirt1 deﬁciency on expression of pluripotency and developmental
markers was more pronounced after induction of differentiation
(Fig. 4 B and C); moreover, the impact on developmental marker
expressionwas greater thanon that of pluripotencymarkers (Fig. 4B
and C). Sirt1 overexpression also resulted in greater alterations
in pluripotency and developmental marker levels when differentia-
tion was induced (Fig. 4C); in contrast to Sirt1 down-regulation,
however, the number of pluripotency and developmental markers
affected in cells overexpressing Sirt1 during differentiation was
similar (≈60%) (Fig. 4C).
We used qPCR to analyze the marker expression in differenti-
ating Sirt1 KO and SuperSirt1 mESC; we tested six pluripotency
(Fgf4, Tdgf1, Nanog, Nodal, Rest, Tdfcp2l1), six neuroectodermal
(NeuroD1, Syp, Nes, Isl1, Sfrp2, Hlxb9), three mesodermal (Co-
l2a1, Brachyury, Des), and three endodermal markers (Fn1, Gata4,
Lama1) (Fig. 5 and Fig. S4C). Sirt1 knockout or overexpression in
undifferentiated mESC had little effect on developmental marker
expression (Fig. 5 and Fig. S4C), in accordance with the expression
array data. During differentiation, both Sirt1 deﬁciency and over-
expression resulted in a clear alteration of most of developmental
markers analyzed (Fig. 5 and Fig. S4C), as in hESC. The greatest
changes were observed in neuroectodermal markers; most were
overexpressed in Sirt1 KO EB and down-regulated in SuperSirt1
EB. These ﬁndings coincide with our data for hESC and indicate
that, in humans and inmice, SIRT1might have an important role in
the establishment of the neuroectodermal layer.
Sirt1 KO mESC showed minor changes in expression of the
pluripotency markers tested; SuperSirt1 mESC markedly overex-
pressed these markers (Fig. 5 and Fig. S4C). Although Sirt1 KO
EB showed no clear changes in pluripotency marker expression
during differentiation, SuperSirt1 EB retained notable expression
of these markers; in most cases, it was comparable to their ex-
pression in WT ES cells.
Our data indicate that Sirt1 affects the expression of develop-
mental genes and, to a lesser extent, of pluripotency genes during
differentiation of human andmouseESC. hESCChIP-on-chip data
indicated that the effect on developmental genes is direct, whereas
the effect on pluripotency genes is mainly indirect. To determine
whether this case is also true for mESC, we used ChIP experiments
to analyze Sirt1 occupancy at the promoters of two pluripotency
(Nanog, Oct4) and three developmental genes (NeuroD1, Nes,
Sfrp2). Expression of the latter is affected by Sirt1 deﬁciency and
overexpression during ES differentiation; Sfrp2 has an important
role in neuroectodermal differentiation (22) and is directly regu-
lated by SIRT1 (23). These experiments showed that Sirt1 bound
Sfrp2 and Nes, but none of the pluripotency gene promoters, sug-
gesting that, as in hESC, Sirt1 preferentially binds developmental
genepromoters inmESC(Fig.S4D).Becausenot all developmental
genes with altered expression in Sirt1-engineered cells were bound
by Sirt1 in ESC, our data suggest that Sirt1 has a direct or indirect
effect on developmental genes, whereas its effect on pluripotency
genes is mainly indirect.
Discussion
Our studies show that SIRT1 regulation of speciﬁc developmental
genes is important in hESC differentiation. Compelling evidence
from mouse models indicates that Sirt1 is a central regulator of
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Fig. 3. SIRT1 binding and regulation of developmental gene
promoters. (A) qChIPof SIRT1 in Shef-1 hESC. Enrichment relative
to a chromatin sample immunoprecipitated without antibody
(NAB) for the SIRT1-bound regions of DLL4, TBX3, SERPINE1,
WNT6, and PAX6 was studied by qPCR. Results are expressed as
the percent enrichment of the bound/unbound ratio (DNA copy
number) of SIRT1 relative to the NAB immunoprecipitate in two
sets of ChIP experiments (ChIP1, ChIP2). The enrichment value of
the Agilent Human Promoters Array Probe (ChIP-chip probe) is
also shown as the percentage of the normalized IP signal divided
by the normalized input signal for the probe giving the highest
signal for each gene represented (Dataset S1). qChIP primers
were designed around the positive probe in the ChIP-on-chip
array. The GAPDH promoter was included as a negative control
for SIRT1 binding and histone modiﬁcations. (B) qChIP of acetyl-
lysine 16 of histone H4 (AcH4K16) and acetyl-lysine 9 of histone
H3 (AcH3K9) in Shef-1 hESC and EB cells. qPCR corresponded to
the same genomic regions described above. Results are
expressed as the bound/unbound percentage ratio (DNA copy
number) for each IP and further normalized for the total H3
enrichment considered constant in chromatin. (C) Expression of
these genes was measured by qPCR in Shef-1 hESC 3 d after
transfection with a control siRNA (SCR) and an siRNA oligo for
SIRT1 (iSIRT1). Data are normalized with respect to GAPDH ex-
pression, relative to the undifferentiated hESC sample (GAPDH
expression set to 100%). qPCR values are mean ± SD of three
independent experiments.
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embryonic (21)and somatic (5) stemcell function. InmESC,Sirt1 is
associated to theDNAdamage response aftermild oxidative stress
(24).Our results extend theseﬁndingsby showing that SIRT1might
be an important regulator of hESCdifferentiation, and also suggest
a molecular pathway for SIRT1 regulation in stem cells. We show
that SIRT1 is down-regulated during hESC differentiation at
mRNA and protein levels and that the mRNA reduction depends
onCARM1-dependentHuRArg217methylation. It was suggested
that Carm1 helps to maintain mESC pluripotency by regulating
histonemethylation at the promoters of speciﬁc pluripotency genes
(25, 26). In addition, Wu et al. (26) showed that developmental
factors are overexpressed after iCarm1, but they did not address
how these genes are up-regulated. Because there is someoverlap of
the iCarm1-overexpressed genes in mESC with those whose pro-
moters are bound by SIRT1 in hESC (Datasets S4 and S5), we
consider that our data and those of Wu et al. help to explain the
central role of CARM1 in pluripotency. CARM1 down-regulation
can have a direct effect on pluripotency by regulating chromatin
structure and an indirect effect on priming developmental genes
through SIRT1 (Fig. 6). This hypothesis would explain our obser-
vation that, at difference from iCARM1, iSIRT1 alone cannot in-
duce hESC differentiation. CARM1 acts on both pluripotency and
differentiation genes, and its knockdown is thus able to force dif-
ferentiation. Repression of pluripotency genes is absolutely neces-
sary to induce ES cell differentiation and, in hESC, SIRT1 appears
to act preferentially on developmental genes.
Because the principal mechanism thought to regulate HuR
function is a change in its cytoplasmic levels (17), we would have
predicted this as the cause of reduced association between HuR
and the SIRT1 transcript. Our results nonetheless suggest that
HuR/SIRT1 mRNA binding relies on CARM1-dependent HuR
methylation, in accordance with the ability of CARM1 to methyl-
ate HuR and the increased HuR/RNA binding activity mediated
by HuR methylation at Arg217 (19). HuR regulation of SIRT1
mRNA is not a new ﬁnding; HuR regulates SIRT1 in cancer cells
(14). Here, we show that HuR also regulates SIRT1 during
hESC differentiation, consistent with the reported role of HuR in
myogenic differentiation (15), suggesting that HuR regulation of
SIRT1 is a common mechanism of stem cell differentiation. It
should nonetheless be stressed that although the CARM1/HuR
pathway described here appears to be the main mechanism in
SIRT1 mRNA down-regulation during hESC differentiation, it is
not alone responsible for SIRT1 control in hESC. The more rapid
down-regulation of SIRT1 protein than of mRNA suggests that
othermechanisms are involved in controlling SIRT1 protein levels.
Our results indicate that elimination of Sirt1 in ES cells had little
impact on the expression of pluripotency and developmental fac-
tors. This observation concurs with previous ﬁndings (27) and
suggests that mammalian ES cells have redundant activities that
mask Sirt1 function. Our data nonetheless show that SIRT1 down-
regulation is needed to establish correct, speciﬁc differentiation
programs during human and mouse ESC differentiation for two
reasons: (i) SIRT1 binds to and epigenetically regulates speciﬁc
developmental genes in pluripotent hESC, and (ii) expression of
Fig. 4. SIRT1 knockdown in hESC and its regulation of the differentiation
program. (A) A TaqMan Human Stem Cell Pluripotency Array that tests ex-
pression of 98 genes was carried out on Shef-1 hESC transfected with control
(SCR) and SIRT1 siRNA (iSIRT1) at 2 d after transfection and after 3 (EB3) and
9 (EB9) d of differentiation of control and knocked-down samples. Results
are shown as the percentage of genes cataloged as pluripotency- or differ-
entiation-related, whose expression changed >2-fold between control and
SIRT1 knocked-down samples at each differentiation stage. (B) A TaqMan
Mouse Stem Cell Pluripotency Array was performed on TC1 mouse ES cells,
the same cell line knocked out for SIRT1, and both lines differentiated in
vitro to 15-d EB. Results are expressed as in A. (C) A TaqMan Array as in Bwas
carried out on SuperSirt1 and the corresponding WT mESC, and both lines
differentiated in vitro to 15-d EB. Results are expressed as in A. qPCR values
are mean ± SD of three independent experiments.
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Fig. 5. Expression of pluripotency and differentiation markers in differen-
tiation of Sirt1 KO (Sirt1−/−) or SuperSirt1 (Sirt1+++) mESC. A marker each for
neuroectodermal (NeuroD1), mesodermal (Des), endodermal (Gata4), and
undifferentiated (Nanog) cells was measured by qPCR in mESC (ES) and 15-d
EB. Data are normalized to Gapdh expression, relative to the undiff-
erentiated ES sample for each line. qPCR values are mean ± SD of three
independent experiments.
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Fig. 6. Model for SIRT1 action on developmental gene promoters during
hESC differentiation. As described by Wu et al. (26), Carm1 regulates pluri-
potency gene promoters by histonemethylation inmESC. In pluripotent hESC,
CARM1 methylation of HuR increases HuR/SIRT1 binding and, consequently,
SIRT1 mRNA stability and the SIRT1 protein level. In these conditions, SIRT1
binds to the promoter and epigenetically represses speciﬁc developmental
genes such as DLL4, PAX6, andWNT6. During differentiation, the decrease in
CARM1 is associated with a decrease in HuR methylation and, consequently,
of HuR/SIRT1 binding, resulting in less SIRT1 mRNA and protein and the epi-
genetic reactivation of developmental genes targeted by SIRT1.
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pluripotency and, above all, of differentiation markers is clearly
altered in differentiating SIRT1-knocked-down hESC and Sirt1
KO/SuperSirt1 mESC. We show that some downstream effects of
SIRT1 down-regulation are mediated by epigenetic reactivation of
speciﬁc developmental genes, consistentwith the role of Sirt1 in cell
differentiation as a component of the polycomb repressive complex
4 (PRC4) (11). SIRT1 function inhESCmaintenancemust bemore
complex, however, because its down-regulation is also associated
with p53 hyperacetylation (this study and refs. 9 and 21). Of the 10
SIRT1 target genes selected for ChIP validation, three (LHX1,
PAX6, WNT6) are associated with neural development (28–30);
another three (DLL4, TBX3, PAX6) are thought to have a role in
retinal morphogenesis (29, 31). These data suggest a SIRT1 con-
tribution to neural fate determination and retina formation during
embryonic development. This possibility is supported by the ﬁnd-
ings that (i) expression of the neuroectodermal markers tested was
clearly up-regulated during Sirt1 KO mESC differentiation and
down-regulatedduringSuperSirt1mESCdifferentiation (Fig. 5 and
Fig. S4C), (ii) Sirt1 is involved indetermining neural progenitor fate
(5), and (iii) Sirt1 KO mice have notable retinal defects (8, 9).
Sirt1 interference and knockout, respectively, during human and
mouse ESC differentiation showed that Sirt1 can also affect plu-
ripotency gene expression. Because the number of pluripotency
genes affected ismuch lower than that of developmental genes and
this regulation is not direct (because Sirt1 rarely binds pluripotency
gene promoters inESC), the role of Sirt1 as a potential regulator of
pluripotency genes is unclear. Although Sirt1 is implicated in
pluripotency maintenance in stem cells, it is not strictly necessary,
because Sirt1 KO mESC do not differentiate spontaneously, Sirt1
KO mice are viable (8, 9), and iSIRT1 in Shef-1 cells does not in
itself induce differentiation (Fig. S3D andG). Sirt1 overexpression
during mESC differentiation altered expression of many more
pluripotency genes than did its depletion in human or mouse ESC,
indicating that abnormally high Sirt1 levels might have an impact
on pluripotency programs. Although we found altered expression
patterns for developmental and pluripotency genes in SuperSirt1
mESC, these mice do not exhibit apparent developmental prob-
lems (20). This discrepancy suggests that, although Sirt1 down-
regulation is delayed during SuperSirt1mESCdifferentiation, with
immediate effects on developmental/pluripotency gene expres-
sion, this alteration is probably compensated in the long term.
In conclusion, our data provide evidence for a previously un-
reported epigenetic pathway in hESC differentiation, in which
SIRT1 regulates hESC differentiation, partly via a CARM1/HuR
pathway (Fig. 6). This pathway involves epigenetic regulation of
key developmental genes such as the neuroretinal morphogen-
esis effectors DLL4, TBX3, and PAX6. In conjunction with the
phenotype of various Sirt1-deﬁcient mouse strains, our results
indicate that whereas SIRT1 has a minor role in promoting or
impairing hESC differentiation, it contributes to the establish-
ment of speciﬁc developmental/differentiation programs of par-
ticular relevance for neuroectodermal fates.
Materials and Methods
Full details are provided in SI Materials and Methods. Brieﬂy, hESC lines were
obtained from the HUCA and the CABIMER, mouse TC1 ES cells and the
knockout ES line (SIRT1Δex4/Δex4) were provided by F. Alt (Harvard Medical
School, Boston), and Sirt1 transgenic ES cells were derived by the CNIO
Transgenic Mouse Unit. Expression of SIRT1, HuR, CARM1, and all pluri-
potency and developmental markers was determined by quantitative RT-
PCR, WB, immunoﬂuorescence, and/or ﬂow cytometry analysis. RNA in-
terference was performed with a modiﬁcation of a reported protocol (32).
HuR-bound mRNA was immunoprecipitated as described (14). The ChIP assay
was carried out as described (33); for the ChIP-on-chip assay, we used the
Agilent Human Promoter Array. For qChIP, PCRs were done with SYBR-green
PCR master mix and analyzed by using the 7900HT Fast Real-Time PCR Sys-
tem (all from Applied Biosystems).
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